{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:54:31Z","timestamp":1792364071546,"version":"4.4.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Immune aplastic anemia (iAA) frequently results in transfusion dependence on platelets and packed red blood cells, increasing the risk for complications. The most common immune-mediated cause for platelet-transfusion refractoriness is alloimmunization with HLA antibody (Ab) to nonself class I antigens. The clinical impact of the HLA alloimmunization has not been well studied in patients with iAA. We investigated the clinical relevance of HLA alloimmunization in our large cohort of patients with iAA from 5 prospective trials and correlated with disease outcomes. Of 444 patients with severe AA treated with immunosuppressive therapy (IST), 99 (22%) had HLA alloimmunization. The presence of HLA Ab was associated with shorter overall survival, reduced responses to IST and higher risk of clonal evolution. Our data suggest that HLA alloimmunization is a marker of disease outcome. Furthermore, using single-cell RNA sequencing, we show enhanced activation of both complement-mediated pathways and the adaptive immune system in alloimmunized patients, indicating an interconnection between immune compartments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015301","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:29:11Z","timestamp":1741976951000},"page":"2639-2650","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-4706","authenticated-orcid":false,"given":"Jibran","family":"Durrani","sequence":"first","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"},{"name":"2Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard N.","family":"Chen","sequence":"additional","affiliation":[{"name":"3Blood Services Section, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba N.","family":"Shalhoub","sequence":"additional","affiliation":[{"name":"4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-1325","authenticated-orcid":false,"given":"Valentina","family":"Baez","sequence":"additional","affiliation":[{"name":"5Laboratory Services Section, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1575-2192","authenticated-orcid":false,"given":"Joshua","family":"Glass","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"},{"name":"6Division of Hematology, Cancer and Blood Disorders Center, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nu Ri","family":"Cha","sequence":"additional","affiliation":[{"name":"5Laboratory Services Section, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Ma","sequence":"additional","affiliation":[{"name":"4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-0819","authenticated-orcid":false,"given":"Zhijie","family":"Wu","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouguo","family":"Gao","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lotter","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Rios","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin O.","family":"Wu","sequence":"additional","affiliation":[{"name":"4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy A.","family":"Flegel","sequence":"additional","affiliation":[{"name":"5Laboratory Services Section, Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-5926","authenticated-orcid":false,"given":"Emma M.","family":"Groarke","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-7701","authenticated-orcid":false,"given":"Bhavisha A.","family":"Patel","sequence":"additional","affiliation":[{"name":"1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"17","key":"2025061009115334800_bib1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"New Engl J Med"},{"issue":"2","key":"2025061009115334800_bib2","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.beha.2021.101276","article-title":"Immunologic effects on the haematopoietic stem cell in marrow failure","volume":"34","author":"Patel","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"2025061009115334800_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood.V58.1.122.122","article-title":"Suppression of transfusion-related alloimmunization in intensively treated cancer patients","volume":"58","author":"Holohan","year":"1981","journal-title":"Blood"},{"issue":"1","key":"2025061009115334800_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/hematology.2020000136","article-title":"How well do platelets prevent bleeding?","volume":"2020","author":"Triulzi","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"2025061009115334800_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1182\/hematology.2020000137","article-title":"Platelet transfusion refractoriness: how do I diagnose and manage?","volume":"2020","author":"Cohn","year":"2020","journal-title":"Hematology"},{"issue":"2","key":"2025061009115334800_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"2025061009115334800_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0268-960X(90)90013-I","article-title":"Platelet transfusions: the problem of refractoriness","volume":"4","author":"Murphy","year":"1990","journal-title":"Blood Rev"},{"issue":"3","key":"2025061009115334800_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2141.1997.812721.x","article-title":"Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia","volume":"97","author":"Killick","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"2025061009115334800_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2003-03-0940","article-title":"Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness","volume":"103","author":"Seftel","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2025061009115334800_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3324\/haematol.2018.189365","article-title":"A subset of anti-HLA antibodies induces Fc\u03b3RIIa-dependent platelet activation","volume":"103","author":"Rijkers","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"2025061009115334800_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1055\/s-0038-1650659","article-title":"The mechanism of platelet aggregation induced by HLA-related antibodies","volume":"76","author":"Brandt","year":"1996","journal-title":"Thromb Haemost"},{"key":"2025061009115334800_bib12","article-title":"Fc gamma receptors and their role in antigen uptake, presentation, and T cell activation","volume":"11:547589","author":"Junker","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"2025061009115334800_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1537-2995.2003.00390.x","article-title":"HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial","volume":"43","author":"Van de Watering","year":"2003","journal-title":"Transfusion"},{"issue":"1","key":"2025061009115334800_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.1987.00011.x-i1","article-title":"Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases","volume":"66","author":"Klingemann","year":"1987","journal-title":"Br J Haematol"},{"issue":"17","key":"2025061009115334800_bib15","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1182\/bloodadvances.2024014143","article-title":"Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patients","volume":"8","author":"Boothby","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"2025061009115334800_bib16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/trf.16411","article-title":"Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: a case report","volume":"61","author":"Hassan","year":"2021","journal-title":"Transfusion"},{"issue":"4","key":"2025061009115334800_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2020.09.010","article-title":"Human leukocyte antigen alloimmunization and alloimmune platelet refractoriness","volume":"34","author":"Saris","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"7","key":"2025061009115334800_bib18","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/trf.15306","article-title":"Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens","volume":"59","author":"Belizaire","year":"2019","journal-title":"Transfusion"},{"issue":"9","key":"2025061009115334800_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.humimm.2018.06.003","article-title":"Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: a multi-center study","volume":"79","author":"Huo","year":"2018","journal-title":"Hum Immunol"},{"issue":"3","key":"2025061009115334800_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V68.3.627.627","article-title":"Quantitative analysis of platelet surface HLA by W6\/32 anti-HLA monoclonal antibody","volume":"68","author":"Kao","year":"1986","journal-title":"Blood"},{"issue":"1","key":"2025061009115334800_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1990.tb02624.x","article-title":"HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects","volume":"75","author":"Botto","year":"1990","journal-title":"Br J Haematol"},{"issue":"2","key":"2025061009115334800_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1537-2995.1990.30290162897.x","article-title":"A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies","volume":"30","author":"Giles","year":"1990","journal-title":"Transfusion"},{"issue":"11","key":"2025061009115334800_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jtct.2021.07.017","article-title":"Transfusions in aplastic anemia patients cause HLA alloimmunization: comparisons of current and past cohorts demonstrate progress","volume":"27","author":"Julen","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"9","key":"2025061009115334800_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtct.2024.05.008","article-title":"The role of pre-existing anti-HLA antibodies in severe aplastic anemia patients undergoing allogenic hematopoietic stem cell transplantation","volume":"30","author":"Wei","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"2025061009115334800_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"","volume":"48","year":"1976","journal-title":"Blood"},{"key":"2025061009115334800_bib26","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","article-title":"Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia","volume":"36","author":"Groarke","year":"2022","journal-title":"Leukemia"},{"issue":"26","key":"2025061009115334800_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"New Engl J Med"},{"issue":"6","key":"2025061009115334800_bib28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/trf.17830","article-title":"Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation","volume":"64","author":"Alswied","year":"2024","journal-title":"Transfusion"},{"key":"2025061009115334800_bib29","doi-asserted-by":"crossref","first-page":"100432","DOI":"10.1016\/j.eclinm.2020.100432","article-title":"The impact of pre-existing HLA and red blood cell antibodies on transfusion support and engraftment in sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation from HLA-matched sibling donors: a prospective, single-center, observational study","volume":"24","author":"Nickel","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"4","key":"2025061009115334800_bib30","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood-2004-10-4080","article-title":"HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients","volume":"107","author":"Nambiar","year":"2006","journal-title":"Blood"},{"key":"2025061009115334800_bib31","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"2025061009115334800_bib32","doi-asserted-by":"crossref","first-page":"101160","DOI":"10.1016\/j.xcrm.2023.101160","article-title":"Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025061009115334800_bib33","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2025061009115334800_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"key":"2025061009115334800_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibri\u00e1n","year":"2017","journal-title":"Eur J Immunol"},{"issue":"1","key":"2025061009115334800_bib36","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/s41467-024-47981-3","article-title":"CD74 supports accumulation and function of regulatory T cells in tumors","volume":"15","author":"Bonnin","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"2025061009115334800_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gene.2011.21","article-title":"IRF7: activation, regulation, modification and function","volume":"12","author":"Ning","year":"2011","journal-title":"Genes Immun"},{"issue":"7","key":"2025061009115334800_bib38","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1002\/ctm2.1671","article-title":"Single-cell sequencing reveals alterations in the differentiation of bone marrow haematopoietic cells in patients with paroxysmal nocturnal haemoglobinuria","volume":"14","author":"Liu","year":"2024","journal-title":"Clin Translational Med"},{"issue":"3","key":"2025061009115334800_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness--practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"12","key":"2025061009115334800_bib39","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1111\/trf.12727","article-title":"Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy","volume":"54","author":"De Clippel","year":"2014","journal-title":"Transfusion"},{"issue":"4","key":"2025061009115334800_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N","article-title":"Platelet transfusions: utilization and associated costs in a tertiary care hospital","volume":"64","author":"Meehan","year":"2000","journal-title":"Am J Hematol"},{"issue":"3","key":"2025061009115334800_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1702490","article-title":"Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation","volume":"26","author":"Toor","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"2025061009115334800_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2017.08.015","article-title":"Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy","volume":"61","author":"Comont","year":"2017","journal-title":"Leuk Res"},{"issue":"1","key":"2025061009115334800_bib44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjh.16298","article-title":"Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease","volume":"189","author":"Nickel","year":"2020","journal-title":"Br J Haematol"},{"issue":"suppl 9","key":"2025061009115334800_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1399-0012.17.s9.2.x","article-title":"The effect of cross-reactive epitope group matching on allocation and sensitization","volume":"17","author":"Crowe","year":"2003","journal-title":"Clin Transpl"},{"issue":"1","key":"2025061009115334800_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","author":"Haematology","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"2025061009115334800_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.seminhematol.2009.03.008","article-title":"Infections in patients with aplastic anemia","volume":"46","author":"Valdez","year":"2009","journal-title":"Semin Hematol"},{"issue":"7","key":"2025061009115334800_bib48","doi-asserted-by":"crossref","first-page":"e20201541","DOI":"10.1084\/jem.20201541","article-title":"Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection","volume":"218","author":"Caiado","year":"2021","journal-title":"J Exp Med"},{"issue":"16","key":"2025061009115334800_bib49","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood.2020005563","article-title":"JAK2-V617F and interferon-\u03b1 induce megakaryocyte-biased stem cells characterized by decreased long-term functionality","volume":"137","author":"Rao","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2025061009115334800_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br J Haematol"},{"issue":"9","key":"2025061009115334800_bib51","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3324\/haematol.2011.042622","article-title":"Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia","volume":"96","author":"Afable","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"2025061009115334800_bib52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00277-013-1674-8","article-title":"The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study","volume":"92","author":"Shin","year":"2013","journal-title":"Ann Hematol"},{"issue":"4","key":"2025061009115334800_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pbc.25820","article-title":"Markedly high plasma thrombopoietin (TPO) level is a predictor of poor response to immunosuppressive therapy in children with acquired severe aplastic anemia","volume":"63","author":"Elmahdi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2025061009115334800_bib54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/ejh.13057","article-title":"Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia-a Swedish nationwide cohort study","volume":"100","author":"Vaht","year":"2018","journal-title":"Eur J Haematol"},{"issue":"2","key":"2025061009115334800_bib55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0609.2009.01378.x","article-title":"Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia","volume":"84","author":"Chang","year":"2010","journal-title":"Eur J Haematol"},{"issue":"7","key":"2025061009115334800_bib56","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00277-015-2348-5","article-title":"The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia","volume":"94","author":"Zhao","year":"2015","journal-title":"Ann Hematol"},{"issue":"5","key":"2025061009115334800_bib57","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3324\/haematol.2010.032805","article-title":"Predicting response to immunosuppressive therapy in childhood aplastic anemia","volume":"96","author":"Yoshida","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"2025061009115334800_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ajh.24897","article-title":"Clinical outcomes in adult patients with aplastic anemia: a single institution experience","volume":"92","author":"Boddu","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"2025061009115334800_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3324\/haematol.2021.278413","article-title":"Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag","volume":"107","author":"Zaimoku","year":"2022","journal-title":"Haematologica"},{"issue":"9","key":"2025061009115334800_bib60","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood-2016-03-703702","article-title":"Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment","volume":"128","author":"Kordasti","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2025061009115334800_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjh.16651","article-title":"Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia","volume":"190","author":"Zaimoku","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"2025061009115334800_bib62","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3324\/haematol.2015.132530","article-title":"Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia","volume":"100","author":"Narita","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"2025061009115334800_bib63","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2013.091165","article-title":"Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia","volume":"99","author":"Sakaguchi","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"2025061009115334800_bib64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"2025061009115334800_bib65","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","article-title":"Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia","volume":"107","author":"Sugimori","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2025061009115334800_bib66","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.12661","article-title":"Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study","volume":"164","author":"Kulagin","year":"2014","journal-title":"Br J Haematol"},{"key":"2025061009115334800_bib67","doi-asserted-by":"crossref","first-page":"1125367","DOI":"10.3389\/fimmu.2023.1125367","article-title":"Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: from mechanisms and determinants to therapeutic prospects","volume":"14","author":"Couvidou","year":"2023","journal-title":"Front Immunol"},{"issue":"18","key":"2025061009115334800_bib68","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197405022901803","article-title":"Phagocytosis of antibody-coated platelets by human granulocytes","volume":"290","author":"Handin","year":"1974","journal-title":"New Engl J Med"},{"issue":"10","key":"2025061009115334800_bib69","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.exphem.2016.07.004","article-title":"The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia","volume":"44","author":"Aslam","year":"2016","journal-title":"Exp Hematol"},{"key":"2025061009115334800_bib70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/tme.13107","article-title":"Blood donation practices, motivators and barriers in the Caribbean: a narrative review","volume":"35","author":"Reid","year":"2024","journal-title":"Transfus Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/11\/2639\/2376844\/blooda_adv-2024-015301-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/11\/2639\/2376844\/blooda_adv-2024-015301-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:12:07Z","timestamp":1749546727000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/11\/2639\/536047\/Impact-of-HLA-alloimmunization-on-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,6,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015301","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,10]]},"published":{"date-parts":[[2025,5,28]]}}}